This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 112/18/2857    most recent CIRCULATIONAHA.105.554832v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tamaki, T. Articles by Asahara, T. Search for Related Content PubMed PubMed Citation Articles by Tamaki, T. Articles by Asahara, T. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Stem Cells Related Collections Angiogenesis Animal models of human disease Endothelium/vascular type/nitric oxide Other Vascular biology Other Research

(Circulation. 2005;112:2857-2866.)
© 2005 American Heart Association, Inc.

Vascular Medicine

Functional Recovery of Damaged Skeletal Muscle Through Synchronized Vasculogenesis, Myogenesis, and Neurogenesis by Muscle-Derived Stem Cells

Tetsuro Tamaki, PhD; Yoshiyasu Uchiyama, MD, PhD; Yoshinori Okada, BS; Tetsuya Ishikawa, PhD; Masahiro Sato, PhD; Akira Akatsuka, BS; Takayuki Asahara, MD, PhD

From the Department of Regenerative Medicine, Division of Basic Clinical Science (T.T., T.I., T.A.), the Department of Orthopedics (Y.U.), and the Teaching and Research Support Center (Y.O., A.A.), Tokai University School of Medicine, and the Institute of Medical Sciences, Tokai University (M.S.), Kanagawa; and the Institute of Biomedical Research and Innovation, Division of Stem Cell Translational Research (T.A.), and the RIKEN Center of Developmental Biology, Stem Cell Translational Research Team, Kobe (T.A.), Japan.

Correspondence to Tetsuro Tamaki, PhD, Muscle Physiology and Cell Biology Unit, Department of Regenerative Medicine, Division of Basic Clinical Science, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan. E-mail tamaki{at}is.icc.u-tokai.ac.jp

Received April 9, 2005; revision received August 4, 2005; accepted August 8, 2005.

Background— Recent studies have shown that skeletal muscle–derived stem cells (MDSCs) can give rise to several cell lineages after transplantation. However, the potential therapeutic uses of MDSCs, the functional significance of the transplanted tissue, and vasculogenesis, myogenesis, and reconstitution of other tissues have yet to be investigated in detail. In addition, the relationship between MDSCs and mesenchymal bone marrow cells is of interest.

Methods and Results— We developed a severe-damage model of mouse tibialis anterior muscle with a large deficit of nerve fibers, muscle fibers, and blood vessels. We investigated the potential therapeutic use of freshly isolated CD34⁺/45^– (Sk-34) cells. Results showed that, after transplantation, implanted cells give rise to myogenic, vascular (pericytes, vascular smooth muscle cells, and endothelial cells), and neural (Schwann) cells, as well as contributing to the synchronized reconstitution of blood vessels, muscle fibers, and peripheral nerves, with significant recovery of both mass and contractile function after transplantation. Investigation of Sk-34 cell transplantation to the renal capsule (nonmuscle tissue) and fluorescence in situ hybridization analysis for the transplanted muscle detecting the Y chromosome revealed the intrinsic plasticity of the Sk-34 cell population. In addition, there were no donor-derived Sk-34 cells in the muscle of lethally irradiated bone marrow–transplanted animals, indicating that the Sk-34 cells were not derived from bone marrow.

Conclusions— These findings indicate that freshly isolated skeletal muscle–derived Sk-34 cells are potentially useful for reconstitution therapy of the vascular, muscular, and peripheral nervous systems. These results provide new insights into somatic stem and/or progenitor cells with regard to vasculogenesis, myogenesis, and neurogenesis.

Key Words: angiogenesis • stem cells • endothelium • transplantation • vasculature

This article has been cited by other articles:

				J. B. Pollett, K. A. Corsi, K. R. Weiss, G. M. Cooper, D. A. Barry, B. Gharaibeh, and J. Huard Malignant Transformation of Multipotent Muscle-Derived Cells by Concurrent Differentiation Signals Stem Cells, September 1, 2007; 25(9): 2302 - 2311. [Abstract] [Full Text] [PDF]

				T. Tamaki, Y. Okada, Y. Uchiyama, K. Tono, M. Masuda, M. Wada, A. Hoshi, T. Ishikawa, and A. Akatsuka Clonal Multipotency of Skeletal Muscle-Derived Stem Cells Between Mesodermal and Ectodermal Lineage Stem Cells, September 1, 2007; 25(9): 2283 - 2290. [Abstract] [Full Text] [PDF]

				S. H.A. Wong, K. N. Lowes, I. Bertoncello, A. F. Quigley, P. J. Simmons, M. J. Cook, A. J. Kornberg, and R. M.I. Kapsa Evaluation of Sca-1 and c-Kit As Selective Markers for Muscle Remodelling by Nonhemopoietic Bone Marrow Cells Stem Cells, June 1, 2007; 25(6): 1364 - 1374. [Abstract] [Full Text] [PDF]

				C. Christov, F. Chretien, R. Abou-Khalil, G. Bassez, G. Vallet, F.-J. Authier, Y. Bassaglia, V. Shinin, S. Tajbakhsh, B. Chazaud, et al. Muscle Satellite Cells and Endothelial Cells: Close Neighbors and Privileged Partners Mol. Biol. Cell, April 1, 2007; 18(4): 1397 - 1409. [Abstract] [Full Text] [PDF]

				M. Nakano, K. Satoh, Y. Fukumoto, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa Important Role of Erythropoietin Receptor to Promote VEGF Expression and Angiogenesis in Peripheral Ischemia in Mice Circ. Res., March 16, 2007; 100(5): 662 - 669. [Abstract] [Full Text] [PDF]

				X. Shi and D. J. Garry Muscle stem cells in development, regeneration, and disease. Genes & Dev., July 1, 2006; 20(13): 1692 - 1708. [Abstract] [Full Text] [PDF]